251. Genome-wide association study for ovarian cancer susceptibility using pooled DNA
- Author
-
Nhu D. Le, Matthias Dürst, Madalene Earp, Diether Lambrechts, Yi Lu, Sandrina Lambrechts, Anna deFazio, Angela Brooks-Wilson, Sara H. Olson, Georgia Chenevix-Trench, Honglin Song, Lynne R. Wilkens, Usha Menon, Douglas F. Easton, Rebecca Hein, Shan Wang-Gohrke, Arto Leminen, Susanne K. Kjaer, A Gentry-Maharaj, Paul D.P. Pharoah, Thilo Dörk, Lambertus A. Kiemeney, Irene Orlow, Natalia Bogdanova, Stefan Nickels, Allan Jensen, Ignace Vergotes, Estrid Høgdall, Natalia Antonenkova, Galina Lurie, Lorna Rodriguez-Rodriguez, Simon A. Gayther, Linda S. Cook, Xiaoqing Chen, Susan J. Ramus, Linda E. Kelemen, Elisa V. Bandera, Anne M. van Altena, Marc T. Goodman, Jonathan Tyrer, Heli Nevanlinna, Katja K.H. Aben, Stuart MacGregor, Jonathan Beesley, Michael E. Carney, Ralf Bützow, Leon F.A.G. Massuger, Evelyn Despierre, Tuomas Heikkinen, Sharon E. Johnatty, and Jenny Chang-Claude
- Subjects
Single-nucleotide polymorphism ,Genome-wide association study ,Aetiology, screening and detection [ONCOL 5] ,Polymorphism, Single Nucleotide ,Article ,03 medical and health sciences ,0302 clinical medicine ,Translational research [ONCOL 3] ,Humans ,Medicine ,Genetic Predisposition to Disease ,Genotyping ,Genetics (clinical) ,Aged ,030304 developmental biology ,Genetic association ,Molecular epidemiology Aetiology, screening and detection [NCEBP 1] ,Ovarian Neoplasms ,Genetics ,0303 health sciences ,Hereditary cancer and cancer-related syndromes [ONCOL 1] ,business.industry ,Australia ,Case-control study ,Reproducibility of Results ,Obstetrics and Gynecology ,Cancer ,Middle Aged ,medicine.disease ,Aetiology, screening and detection Immune Regulation [ONCOL 5] ,3. Good health ,SNP genotyping ,Case-Control Studies ,Sample Size ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Female ,Human genome ,business ,Genome-Wide Association Study - Abstract
Contains fulltext : 108021.pdf (Publisher’s version ) (Open Access) Recent Genome-Wide Association Studies (GWAS) have identified four low-penetrance ovarian cancer susceptibility loci. We hypothesized that further moderate- or low-penetrance variants exist among the subset of single-nucleotide polymorphisms (SNPs) not well tagged by the genotyping arrays used in the previous studies, which would account for some of the remaining risk. We therefore conducted a time- and cost-effective stage 1 GWAS on 342 invasive serous cases and 643 controls genotyped on pooled DNA using the high-density Illumina 1M-Duo array. We followed up 20 of the most significantly associated SNPs, which are not well tagged by the lower density arrays used by the published GWAS, and genotyping them on individual DNA. Most of the top 20 SNPs were clearly validated by individually genotyping the samples used in the pools. However, none of the 20 SNPs replicated when tested for association in a much larger stage 2 set of 4,651 cases and 6,966 controls from the Ovarian Cancer Association Consortium. Given that most of the top 20 SNPs from pooling were validated in the same samples by individual genotyping, the lack of replication is likely to be due to the relatively small sample size in our stage 1 GWAS rather than due to problems with the pooling approach. We conclude that there are unlikely to be any moderate or large effects on ovarian cancer risk untagged by less dense arrays. However, our study lacked power to make clear statements on the existence of hitherto untagged small-effect variants. 01 oktober 2012
- Published
- 2012